{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T10:14:56Z","timestamp":1780049696341,"version":"3.53.1"},"reference-count":78,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology and Allergy Clinics of North America"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.iac.2025.09.008","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T08:54:08Z","timestamp":1763369648000},"page":"111-124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Immunotherapy in Allergic and Mixed Rhinitis"],"prefix":"10.1016","volume":"46","author":[{"given":"Tolly","family":"Epstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David I.","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.iac.2025.09.008_bib1","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/all.15023","article-title":"One hundred and ten years of allergen immunotherapy: a journey from empiric observation to evidence","volume":"77","author":"Pfaar","year":"2022","journal-title":"Allergy"},{"issue":"12","key":"10.1016\/j.iac.2025.09.008_bib2","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1111\/all.13208","article-title":"Allergen immunotherapy for allergic asthma: a systematic review and meta-analysis","volume":"72","author":"Dhami","year":"2017","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.iac.2025.09.008_bib3","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/all.13317","article-title":"EAACI guidelines on allergen immunotherapy: allergic rhinoconjunctivitis","volume":"73","author":"Roberts","year":"2018","journal-title":"Allergy"},{"issue":"8","key":"10.1016\/j.iac.2025.09.008_bib4","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1111\/all.13124","article-title":"Allergen immunotherapy for IgE-mediated food allergy: a systematic review and meta-analysis","volume":"72","author":"Nurmatov","year":"2017","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.iac.2025.09.008_bib5","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jaci.2011.03.049","article-title":"Subcutaneous immunotherapy and pharmacotherapy in seasonal allergic rhinitis: a comparison based on meta-analyses","volume":"128","author":"Matricardi","year":"2011","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.iac.2025.09.008_bib6","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1016\/j.jaip.2020.12.008","article-title":"Allergens and adjuvants in allergen immunotherapy for immune activation, tolerance, and resilience","volume":"9","author":"Jensen-Jarolim","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.iac.2025.09.008_bib7","doi-asserted-by":"crossref","first-page":"304","DOI":"10.2500\/ajra.2013.27.3935","article-title":"Perennial is more effective than preseasonal subcutaneous immunotherapy in the treatment of seasonal allergic rhinoconjunctivitis","volume":"27","author":"Tworek","year":"2013","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.iac.2025.09.008_bib8","series-title":"Package insert for RAGWITEK (short Ragweed Pollen Extract). Horsholm, Denmark: manufactured for: ALK-Abello A\/S, Boge Alle 6-8, DK2970","year":"2022"},{"issue":"3","key":"10.1016\/j.iac.2025.09.008_bib9","first-page":"135","article-title":"3-years\u2019 long-term effect of subcutaneous immunotherapy (SCIT) with a high-dose hypoallergenic 6-grass pollen preparation in adults","volume":"44","author":"Dominicus","year":"2012","journal-title":"Eur Ann Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.iac.2025.09.008_bib10","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jaci.2010.10.025","article-title":"Three years of specific immunotherapy may be sufficient in house dust mite respiratory allergy","volume":"127","author":"Tabar","year":"2011","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.iac.2025.09.008_bib11","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/pai.12296","article-title":"Optimal duration of allergen immunotherapy in children with dust mite respiratory allergy","volume":"26","author":"Arroabarren","year":"2015","journal-title":"Pediatr Allergy Immunol"},{"issue":"6","key":"10.1016\/j.iac.2025.09.008_bib12","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1097\/ACI.0000000000000784","article-title":"To mix or not to mix in allergy immunotherapy vaccines","volume":"21","author":"Nelson","year":"2021","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"11","key":"10.1016\/j.iac.2025.09.008_bib13","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1111\/j.1398-9995.2009.02169.x","article-title":"GA2LEN skin test study III: minimum battery of test inhalent allergens needed in epidemiological studies in patients","volume":"64","author":"Bousquet","year":"2009","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.iac.2025.09.008_bib14","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2500\/aap.2021.42.210035","article-title":"Shifts in allergy practice in a COVID-19 world: implications of pre-COVID-19 national health care provider and patient surveys of treatments for nasal allergies","volume":"42","author":"Winders","year":"2021","journal-title":"Allergy Asthma Proc"},{"issue":"4","key":"10.1016\/j.iac.2025.09.008_bib15","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.anai.2011.06.018","article-title":"Allergen immunotherapy practice in the United States: guidelines, measures, and outcomes","volume":"107","author":"Cox","year":"2011","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"23","key":"10.1016\/j.iac.2025.09.008_bib16","first-page":"1819","article-title":"[An analysis of spectrum of allergen sensitization among patients with tree pollen allergy in Beijing]","volume":"31","author":"Wang","year":"2017","journal-title":"Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi"},{"issue":"4","key":"10.1016\/j.iac.2025.09.008_bib17","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.5415\/apallergy.2021.11.e43","article-title":"Efficacy of subcutaneous immunotherapy for patients with asthma and allergic rhinitis in Korea: effect on eosinophilic inflammation","volume":"11","author":"Kim","year":"2021","journal-title":"Asia Pac Allergy"},{"issue":"4","key":"10.1016\/j.iac.2025.09.008_bib18","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.jaci.2008.12.013","article-title":"Multiallergen immunotherapy for allergic rhinitis and asthma","volume":"123","author":"Nelson","year":"2009","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"10.1016\/j.iac.2025.09.008_bib19","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1111\/all.13201","article-title":"Allergen immunotherapy for allergic rhinoconjunctivitis: a systematic review and meta-analysis","volume":"72","author":"Dhami","year":"2017","journal-title":"Allergy"},{"issue":"7","key":"10.1016\/j.iac.2025.09.008_bib20","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1056\/NEJM199908123410702","article-title":"Long-term clinical efficacy of grass-pollen immunotherapy","volume":"341","author":"Durham","year":"1999","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.iac.2025.09.008_bib21","doi-asserted-by":"crossref","DOI":"10.1002\/iid3.1004","article-title":"House dust mite subcutaneous immunotherapy has sustained long-term effectiveness on allergic rhinitis and asthma: a 10-year follow-up","volume":"11","author":"Rodriguez-Plata","year":"2023","journal-title":"Immun Inflamm Dis"},{"issue":"1 Suppl","key":"10.1016\/j.iac.2025.09.008_bib22","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaci.2010.09.034","article-title":"Allergen immunotherapy: a practice parameter third update","volume":"127","author":"Cox","year":"2011","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.iac.2025.09.008_bib23","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/ACI.0000000000000457","article-title":"Does evidence support the use of cat allergen immunotherapy?","volume":"18","author":"Dhami","year":"2018","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2025.09.008_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/falgy.2024.1417879","article-title":"A human monoclonal antibody based immunoenzymetric assay to measure Fel d 1 concentrations in cat hair and pelt allergenic extracts","volume":"5","author":"Rabin","year":"2024","journal-title":"Front Allergy"},{"issue":"1","key":"10.1016\/j.iac.2025.09.008_bib25","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1067\/mai.2003.41","article-title":"A double-blind, placebo-controlled immunotherapy dose-response study with standardized cat extract","volume":"111","author":"Ewbank","year":"2003","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.iac.2025.09.008_bib26","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.jaci.2004.08.049","article-title":"Dose dependence and time course of the immunologic response to administration of standardized cat allergen extract","volume":"114","author":"Nanda","year":"2004","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.iac.2025.09.008_bib27","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.anai.2010.11.004","article-title":"Analysis of allergen specific IgE cut points to cat and dog in the childhood allergy study","volume":"106","author":"Linden","year":"2011","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"10.1016\/j.iac.2025.09.008_bib28","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4168\/aair.2018.10.2.97","article-title":"Dog and cat allergies: current state of diagnostic approaches and challenges","volume":"10","author":"Chan","year":"2018","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.iac.2025.09.008_bib29","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13223-016-0167-4","article-title":"Analysis of feline and canine allergen components in patients sensitized to pets","volume":"12","author":"Ukleja-Sokolowska","year":"2016","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"2","key":"10.1016\/j.iac.2025.09.008_bib30","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jaci.2008.11.021","article-title":"Prostatic kallikrein: a new major dog allergen","volume":"123","author":"Mattsson","year":"2009","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.iac.2025.09.008_bib31","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.jaci.2011.10.017","article-title":"Identification of a new major dog allergen highly cross-reactive with Fel d 4 in a population of cat- and dog-sensitized patients","volume":"129","author":"Hilger","year":"2012","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.iac.2025.09.008_bib32","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.jaci.2014.08.026","article-title":"Allergy to furry animals: new insights, diagnostic approaches, and challenges","volume":"135","author":"Konradsen","year":"2015","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.iac.2025.09.008_bib33","first-page":"41","article-title":"Allergy to laboratory animals: an epidemiological study","volume":"49","author":"Aoyama","year":"1992","journal-title":"Br J Ind Med"},{"issue":"6","key":"10.1016\/j.iac.2025.09.008_bib34","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/0091-6749(80)90233-X","article-title":"Efficacy and specificity of immunotherapy with laboratory animal allergen extracts","volume":"65","author":"Wahn","year":"1980","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.iac.2025.09.008_bib35","first-page":"29","article-title":"Clinical experience with specific immunotherapy to horse dander","volume":"12","author":"Fernandez-Tavora","year":"2002","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"6","key":"10.1016\/j.iac.2025.09.008_bib36","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2500\/aap.2023.44.230058","article-title":"Allergy immunotherapy for allergic fungal respiratory diseases","volume":"44","author":"Nelson","year":"2023","journal-title":"Allergy Asthma Proc"},{"issue":"2","key":"10.1016\/j.iac.2025.09.008_bib37","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jaci.2003.11.024","article-title":"Manufacturing and standardizing fungal allergen products","volume":"113","author":"Esch","year":"2004","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.iac.2025.09.008_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaip.2023.10.039","article-title":"The art of immunotherapy","volume":"12","author":"Nelson","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.iac.2025.09.008_bib39","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.anai.2012.04.012","article-title":"Allergen stabilities and compatibilities in mixtures of high-protease fungal and insect extracts","volume":"108","author":"Grier","year":"2012","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"11","key":"10.1016\/j.iac.2025.09.008_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8112019","article-title":"Allergic and mixed rhinitis: diagnosis and natural evolution","volume":"8","author":"Greiwe","year":"2019","journal-title":"J Clin Med"},{"issue":"3","key":"10.1016\/j.iac.2025.09.008_bib41","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.anai.2012.06.013","article-title":"Clinical characteristics of chronic rhinitis patients with high vs low irritant trigger burdens","volume":"109","author":"Bernstein","year":"2012","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"10.1016\/j.iac.2025.09.008_bib42","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S1081-1206(10)63546-6","article-title":"Questionnaire evaluation and risk factor identification for nonallergic vasomotor rhinitis","volume":"96","author":"Brandt","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"10.1016\/j.iac.2025.09.008_bib43","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2500\/aap.2011.32.3400","article-title":"Is response to allergen immunotherapy a good phenotypic marker for differentiating between allergic rhinitis and mixed rhinitis?","volume":"32","author":"Smith","year":"2011","journal-title":"Allergy Asthma Proc"},{"issue":"1","key":"10.1016\/j.iac.2025.09.008_bib44","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.anai.2021.03.011","article-title":"Risk factors for fatal and nonfatal reactions to immunotherapy (2008-2018): postinjection monitoring and severe asthma","volume":"127","author":"Epstein","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"10.1016\/j.iac.2025.09.008_bib45","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.anai.2016.02.001","article-title":"Risk factors for fatal and nonfatal reactions to subcutaneous immunotherapy: national surveillance study on allergen immunotherapy (2008-2013)","volume":"116","author":"Epstein","year":"2016","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"5","key":"10.1016\/j.iac.2025.09.008_bib46","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.anai.2016.09.005","article-title":"Comparison of systemic reactions in rush, cluster, and standard-build aeroallergen immunotherapy","volume":"117","author":"Winslow","year":"2016","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"9","key":"10.1016\/j.iac.2025.09.008_bib47","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1016\/j.jaip.2023.06.028","article-title":"Comparison of standard, cluster, and rush allergy immunotherapy buildup protocols","volume":"11","author":"Lee","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"46","key":"10.1016\/j.iac.2025.09.008_bib48","doi-asserted-by":"crossref","first-page":"17908","DOI":"10.1073\/pnas.0803725105","article-title":"Intralymphatic allergen administration renders specific immunotherapy faster and safer: a randomized controlled trial","volume":"105","author":"Senti","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.iac.2025.09.008_bib49","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/j.jaci.2012.02.026","article-title":"Intralymphatic immunotherapy for cat allergy induces tolerance after only 3 injections","volume":"129","author":"Senti","year":"2012","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.iac.2025.09.008_bib50","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.anai.2015.11.010","article-title":"Three-injection intralymphatic immunotherapy in adolescents and young adults with grass pollen rhinoconjunctivitis","volume":"116","author":"Patterson","year":"2016","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"10.1016\/j.iac.2025.09.008_bib51","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/alr.23090","article-title":"International consensus statement on allergy and rhinology: allergic rhinitis - 2023","volume":"13","author":"Wise","year":"2023","journal-title":"Int Forum Allergy Rhinol"},{"issue":"7","key":"10.1016\/j.iac.2025.09.008_bib52","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1111\/all.16491","article-title":"Six injections of modified adjuvanted PQ grass is effective and well-tolerated in a pivotal phase III trial","volume":"80","author":"Zielen","year":"2025","journal-title":"Allergy"},{"issue":"7","key":"10.1016\/j.iac.2025.09.008_bib53","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1111\/all.16535","article-title":"Meta-analysis of PQ grass 27600 SU efficacy and quality of life from phase III trials","volume":"80","author":"Zielen","year":"2025","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.iac.2025.09.008_bib54","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.jaci.2018.12.1001","article-title":"The SQ tree SLIT-tablet is highly effective and well tolerated: results from a randomized, double-blind, placebo-controlled phase III trial","volume":"143","author":"Biedermann","year":"2019","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.iac.2025.09.008_bib55","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.jaci.2018.11.018","article-title":"Sublingual allergen immunotherapy with a liquid birch pollen product in patients with seasonal allergic rhinoconjunctivitis with or without asthma","volume":"143","author":"Pfaar","year":"2019","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.iac.2025.09.008_bib56","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/all.13606","article-title":"A birch sublingual allergy immunotherapy tablet reduces rhinoconjunctivitis symptoms when exposed to birch and oak and induces IgG(4) to allergens from all trees in the birch homologous group","volume":"74","author":"Couroux","year":"2019","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.iac.2025.09.008_bib57","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jaci.2010.11.035","article-title":"Efficacy and safety of timothy grass allergy immunotherapy tablet treatment in North American adults","volume":"127","author":"Nelson","year":"2011","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.iac.2025.09.008_bib58","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.jaci.2013.10.041","article-title":"Randomized, double-blind, placebo-controlled trial of standardized ragweed sublingual-liquid immunotherapy for allergic rhinoconjunctivitis","volume":"133","author":"Creticos","year":"2014","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.iac.2025.09.008_bib59","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/j.jaci.2016.06.044","article-title":"Efficacy of house dust mite sublingual immunotherapy tablet in North American adolescents and adults in a randomized, placebo-controlled trial","volume":"138","author":"Nolte","year":"2016","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.iac.2025.09.008_bib60","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.jaci.2012.08.032","article-title":"Clinical efficacy of 300IR 5-grass pollen sublingual tablet in a US study: the importance of allergen-specific serum IgE","volume":"130","author":"Cox","year":"2012","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.iac.2025.09.008_bib61","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/j.jaci.2014.12.1911","article-title":"Onset and dose-related efficacy of house dust mite sublingual immunotherapy tablets in an environmental exposure chamber","volume":"135","author":"Nolte","year":"2015","journal-title":"J Allergy Clin Immunol"},{"issue":"16","key":"10.1016\/j.iac.2025.09.008_bib62","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1001\/jama.2016.3964","article-title":"Efficacy of a house dust mite sublingual allergen immunotherapy tablet in adults with allergic asthma: a randomized clinical trial","volume":"315","author":"Virchow","year":"2016","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.iac.2025.09.008_bib63","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jaip.2021.10.060","article-title":"Efficacy of house dust mite sublingual immunotherapy in patients with atopic dermatitis: a randomized, double-blind, placebo-controlled trial","volume":"10","author":"Langer","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"7","key":"10.1016\/j.iac.2025.09.008_bib64","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1016\/j.jaip.2020.03.041","article-title":"Efficacy and safety of ragweed SLIT-tablet in children with allergic rhinoconjunctivitis in a randomized, placebo-controlled trial","volume":"8","author":"Nolte","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.iac.2025.09.008_bib65","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jaci.2017.06.014","article-title":"Results from the 5-year SQ grass sublingual immunotherapy tablet asthma prevention (GAP) trial in children with grass pollen allergy","volume":"141","author":"Valovirta","year":"2018","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.iac.2025.09.008_bib66","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.anai.2014.04.018","article-title":"Safety and tolerability of a short ragweed sublingual immunotherapy tablet","volume":"113","author":"Nolte","year":"2014","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.iac.2025.09.008_bib67","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13601-015-0057-8","article-title":"Prolonged efficacy of the 300IR 5-grass pollen tablet up to 2 years after treatment cessation, as measured by a recommended daily combined score","volume":"5","author":"Didier","year":"2015","journal-title":"Clin Transl Allergy"},{"issue":"Suppl 95","key":"10.1016\/j.iac.2025.09.008_bib68","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1398-9995.2011.02639.x","article-title":"Sustained effects of grass pollen AIT","volume":"66","author":"Durham","year":"2011","journal-title":"Allergy"},{"issue":"6","key":"10.1016\/j.iac.2025.09.008_bib69","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1080\/00325481.2017.1302306","article-title":"A practical guide to the sublingual immunotherapy tablet adverse event profile: implications for clinical practice","volume":"129","author":"Bernstein","year":"2017","journal-title":"Postgrad Med J"},{"issue":"1","key":"10.1016\/j.iac.2025.09.008_bib70","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jaip.2023.11.011","article-title":"Anaphylaxis in clinical trials of sublingual immunotherapy tablets","volume":"12","author":"Nolte","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.iac.2025.09.008_bib71","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jaci.2015.12.1298","article-title":"Sublingual or subcutaneous immunotherapy for allergic rhinitis?","volume":"137","author":"Durham","year":"2016","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.iac.2025.09.008_bib72","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.jaip.2024.04.034","article-title":"Allergen immunotherapy: the evidence supporting the efficacy and safety of subcutaneous immunotherapy and sublingual forms of immunotherapy for allergic rhinitis\/conjunctivitis and asthma","volume":"12","author":"Creticos","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.iac.2025.09.008_bib73","article-title":"Long-term real-world effectiveness of allergy immunotherapy in patients with allergic rhinitis and asthma: results from the REACT study, a retrospective cohort study","volume":"13","author":"Fritzsching","year":"2022","journal-title":"Lancet Reg Health Eur"},{"issue":"2","key":"10.1016\/j.iac.2025.09.008_bib74","doi-asserted-by":"crossref","first-page":"108","DOI":"10.2500\/aap.2020.41.200001","article-title":"Safety of allergen immunotherapy in North America from 2008-2017: lessons learned from the ACAAI\/AAAAI National Surveillance Study of adverse reactions to allergen immunotherapy","volume":"41","author":"Bernstein","year":"2020","journal-title":"Allergy Asthma Proc"},{"issue":"4","key":"10.1016\/j.iac.2025.09.008_bib75","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0091-6749(87)80164-1","article-title":"Fatalities from immunotherapy (IT) and skin testing (ST)","volume":"79","author":"Lockey","year":"1987","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.iac.2025.09.008_bib76","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.jaci.2004.02.006","article-title":"Immunotherapy Committee AAoAA, immunology. Twelve-year survey of fatal reactions to allergen injections and skin testing: 1990-2001","volume":"113","author":"Bernstein","year":"2004","journal-title":"J Allergy Clin Immunol"},{"issue":"1 Pt 1","key":"10.1016\/j.iac.2025.09.008_bib77","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/0091-6749(93)90030-J","article-title":"Survey of fatalities from skin testing and immunotherapy 1985-1989","volume":"92","author":"Reid","year":"1993","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.iac.2025.09.008_bib78","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1016\/j.jaip.2019.01.058","article-title":"AAAAI\/ACAAI subcutaneous immunotherapy surveillance study (2013-2017): fatalities, infections, delayed reactions, and use of epinephrine autoinjectors","volume":"7","author":"Epstein","year":"2019","journal-title":"J Allergy Clin Immunol Pract"}],"container-title":["Immunology and Allergy Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856125000797?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856125000797?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T12:33:35Z","timestamp":1763469215000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889856125000797"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":78,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S0889856125000797"],"URL":"https:\/\/doi.org\/10.1016\/j.iac.2025.09.008","relation":{},"ISSN":["0889-8561"],"issn-type":[{"value":"0889-8561","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunotherapy in Allergic and Mixed Rhinitis","name":"articletitle","label":"Article Title"},{"value":"Immunology and Allergy Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iac.2025.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}